0000000000423545
AUTHOR
J. Ritchie
Search for Production of Invisible Final States in Single-Photon Decays of Υ(1S)
We search for single-photon decays of the Upsilon(1S) resonance, Upsilon->gamma+invisible, where the invisible state is either a particle of definite mass, such as a light Higgs boson A0, or a pair of dark matter particles, chi chi-bar. Both A0 and chi are assumed to have zero spin. We tag Upsilon(1S) decays with a dipion transition Upsilon(2S)->pi+pi-Upsilon(1S) and look for events with a single energetic photon and significant missing energy. We find no evidence for such processes in the mass range m_A0<=9.2 GeV and m_chi<=4.5 GeV in the sample of 98e6 Upsilon(2S) decays collected with the BaBar detector and set stringent limits on new physics models that contain light dark ma…
Association Between Tumor Egfr and Kras Mutation Status and Clinical Outcomes in Nsclc Patients Randomized to Sorafenib Plus Best Supportive Care (BSC) or Bsc Alone: Subanalysis of the Phase III Mission Trial
ABSTRACT Background Tumor EGFR and KRas mutations are both predictive and prognostic biomarkers in patients with advanced NSCLC. We analyzed the correlation between these biomarkers and treatment outcomes in a phase III trial of 3rd/4th line sorafenib in patients with NSCLC. Methods The global, randomized, placebo-controlled MISSION trial enrolled 703 patients with advanced relapsed/refractory NSCLC of predominantly non-squamous histology. The primary study endpoint was overall survival (OS). EGFR and KRas mutations were analyzed in archival tumor samples and in circulating tumor DNA isolated from plasma. Results Tumor and/or plasma mutation data were available from 347 patients (49%). EGFR…